Patents Assigned to Regenexx, LLC
-
Patent number: 12636661Abstract: Apparatus, system, and method embodiments provide a fractionation device for the fractionation or separation of blood or bone marrow aspirate (BMA) into one or more component layers and the efficient collection of layers of interest. The fractionation device includes a generally cylindrical sidewall, a top wall connected to an upper portion of the sidewall, a bottom wall connected to a lower portion of the sidewall, and an interior partition. The interior partition includes a sloped portion contacting the sidewall and a vertical portion contacting the top wall.Type: GrantFiled: June 13, 2023Date of Patent: May 26, 2026Assignee: REGENEXX, LLCInventors: Michael Masters, Christopher Centeno, Matthew Murphy, Matthew Cooksey, Dustin Berger, Neven Steinmetz
-
Patent number: 12233188Abstract: The embodiments disclosed herein generally relate to systems, devices and methods for the fractionation, isolation, extraction and processing of the adipose supernatant layer of a bone marrow aspirate. In particular, the various embodiments relate to systems, devices, and methods of obtaining, utilizing, and processing the adipose supernatant layer of a bone marrow aspirate as a source of mesenchymal stem cells.Type: GrantFiled: January 6, 2022Date of Patent: February 25, 2025Assignee: Regenexx, LLCInventors: Christopher Centeno, Ryan Dregalla, Nicolette Lyons, Patrick Reischling
-
Patent number: 11903970Abstract: Apparatus, kit and method embodiments are disclosed herein that provide for the production of a modified autologous platelet mixture at a patient bedside for contemporaneous reinjection to the patient using a platelet lysis apparatus. Representative platelet lysis apparatus may include a housing supporting a sample tube and a thermal mass element connected to or near the sample tube. The thermal mass element may be separable from the housing, and/or the sample tube may be separable from the thermal mass element.Type: GrantFiled: December 23, 2020Date of Patent: February 20, 2024Assignee: Regenexx, LLCInventors: Christopher J. Centeno, Neven Steinmetz, Ian Stemper, Dustin Berger
-
Patent number: 11278573Abstract: Compositions and methods are provided for repairing damaged avascular zones, including intervertebral disc, in a patient in need thereof.Type: GrantFiled: June 14, 2019Date of Patent: March 22, 2022Assignee: REGENEXX, LLCInventor: Christopher J. Centeno
-
Patent number: 10898497Abstract: Autologous compositions and methods are provided for cartilage repair in patients in need thereof. Some aspects include combinations of platelet-based materials with chondrogenesis inducing agents in the presence or absence of cell-based therapies.Type: GrantFiled: September 29, 2015Date of Patent: January 26, 2021Assignee: REGENEXX, LLCInventor: Christopher J. Centeno
-
Patent number: 10350372Abstract: Embodiments include systems, methods and devices for the percutaneous delivery of therapeutic agents to tendons, ligaments and muscle. Certain embodiments include a device comprising a needle-catheter based delivery system with adjustable characteristics to allow a clinician to control the angle and depth of needle and/or catheter deployment to a desired location. System embodiments may include a controller unit where a clinician can adjust the axial position depth and location of needles and/or catheters.Type: GrantFiled: January 20, 2015Date of Patent: July 16, 2019Assignee: Regenexx, LLCInventors: Christopher Centeno, Patrick Reischling, Timothy Snyder
-
Patent number: 10088391Abstract: Apparatus, systems and methods for processing a blood sample. One embodiment comprises an isolation container having at least one sidewall defining an interior volume. The interior volume includes a medial reservoir in fluid communication with proximal and distal reservoirs. The diameter of the medial reservoir is less than the diameter of the proximal and distal reservoirs. Therefore, the isolation container has an interior volume which is roughly hour-glass shaped with the medial reservoir being a substantially narrowed portion or channel between two wider portions. The isolation container is configured such that the buffy coat layer of fractionated blood will be located within and may be accessed from the reduced cross sectional medial reservoir after a centrifuge or other processing step.Type: GrantFiled: February 18, 2014Date of Patent: October 2, 2018Assignee: Regenexx, LLCInventors: Christopher J. Centeno, Brian Leach, Ryan Dregalla, Patrick Reischling
-
Patent number: 9976115Abstract: The embodiments disclosed herein generally relate to systems, devices and methods for the fractionation, isolation, extraction and processing of the adipose supernatant layer of a bone marrow aspirate. In particular, the various embodiments relate to systems devices and methods of obtaining, utilizing and processing the adipose supernatant layer of a bone marrow aspirate as a source of mesenchymal stem cells.Type: GrantFiled: August 6, 2014Date of Patent: May 22, 2018Assignee: Regenexx, LLCInventors: Christopher Centeno, Ryan Dregalla, Nicolette Lyons, Patrick Reischling
-
Patent number: D1146059Type: GrantFiled: November 1, 2024Date of Patent: September 1, 2026Assignee: REGENEXX, LLCInventors: Michael Masters, Christopher Centeno, Matthew Murphy, Matthew Cooksey, Dustin Berger, Neven Steinmetz